GLOW Blend
GLOW Blend (GHK-Cu / BPC-157 / TB500)
GHK-Cu
BPC-157
TB500Blend components — PubChem
Research Hub — Aggregated Studies
MedTech Research Group aggregates published research from peer-reviewed journals, clinical trials, and academic institutions. We do not conduct original research. All studies cited below are the work of their respective authors and institutions. Sources are linked for verification.
This product is designated FOR RESEARCH USE ONLY (RUO). These compounds have not been approved or cleared under 21 U.S.C. § 505 and have not been evaluated by the FDA for safety, efficacy, or labeling for clinical, diagnostic, or therapeutic use in humans or animals.
MedTech Research Group will only fulfill orders to qualified researchers affiliated with accredited academic institutions, licensed research facilities, or organizations with active IRB/IACUC oversight.
Purchaser Restrictions
- Purchaser must be a qualified researcher at an accredited institution or licensed research facility
- This product may not be sold or redistributed to individual consumers, wellness clinics, health food stores, or retail establishments
- Not intended for human or animal consumption, diagnostic use, or therapeutic application
- Institutional affiliation and research purpose will be verified prior to order fulfillment
Distribution is limited to qualified research use in compliance with applicable federal and state law. These products bear the "For Research Use Only" designation per FDA labeling requirements (minimum 10 pt. font). Ref: 21 U.S.C. § 505; FD&C Act § 201(p) (unapproved new drug definition).
| Risk Tier | YELLOW |
| Category | Skin / Cosmetic |
| Subcategory | Multi-Peptide Skin Rejuvenation |
| Pharmacological Class | Combination Peptide |
| Subclass | Copper Peptide + Cytoprotective + Actin-Sequestering Blend |
| Molecular Type | Three-peptide lyophilized combination |
| Origin | All synthetic components |
| Regulatory Status | Research Use Only |
| Route of Administration | Subcutaneous injection |
| Reconstitution | Lyophilized powder; reconstitute with bacteriostatic water |
| Storage | Refrigerate (2-8°C) |
Description
The GLOW Blend is a three-peptide combination formulated specifically for skin rejuvenation and cosmetic research applications. It combines GHK-Cu (the copper tripeptide that drives collagen synthesis and gene expression remodeling), BPC-157 (the gastric pentadecapeptide that stimulates angiogenesis and tissue repair), and TB500 (the actin-regulatory peptide that promotes cell migration and reduces inflammation). Each component addresses a different aspect of skin aging and repair.
GHK-Cu provides the collagen-stimulating and gene-expression-modulating backbone of the formulation. BPC-157 contributes its angiogenic properties — new blood vessel formation is critical for delivering nutrients to aging skin and supporting the metabolic demands of increased collagen production. TB500 facilitates the migration of fibroblasts and stem cells into areas of skin damage or aging, while simultaneously reducing the chronic low-grade inflammation (inflammaging) that accelerates skin aging.
The combination name "GLOW" reflects its intended cosmetic application — improving skin luminosity, texture, and overall appearance. The GLOW Blend generated $41,000 in revenue across the YPB network with 457 units sold, indicating strong demand in the aesthetic/cosmetic market segment.
Clinical Context
The GLOW Blend targets the cosmetic and aesthetic research market by combining three peptides with complementary mechanisms for skin rejuvenation. GHK-Cu drives collagen synthesis and gene expression remodeling, BPC-157 provides angiogenic support for nutrient delivery, and TB500 facilitates cell migration and reduces inflammaging. The blend generated $41,000 in revenue across the YPB network with 457 units sold, indicating strong demand in the aesthetic market segment.
- All individual component warnings apply (see GHK-Cu, BPC-157, TB500 sections)
- Cost analysis: purchasing components separately would cost approximately $107.67 vs. $81.96 for the blend — the blend offers a 24% cost savings
- The Standard Catalog version (YPB.109) contains slightly less GHK-Cu (45mg vs. 50mg) at significantly higher cost
Published Research
Published Research & Clinical Data
Peer-reviewed studies and clinical trial data related to GLOW Blend
All research below is conducted by independent institutions. MedTech Research Group provides these references for informational purposes only.
Research citations are being compiled for this compound.
Check back soon — our team is curating peer-reviewed sources.